The AJMC® Asthma compendium is a comprehensive resource for clinical news and expert insights for the chronic lung disease.
December 17th 2025
Twice-yearly depemokimab cuts asthma exacerbations in phase 3 trials for patients aged 12 and older with severe eosinophilic asthma.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage
1.5 Credits / Immunization, Infectious Disease, Pulmonology
View More
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
1.5 Credits / Immunology, Pulmonology
View More
Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists
1.5 Credits / Pulmonology
View More
Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies
1.5 Credits / Pulmonology, Cardiology, Rare Diseases
View More
Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC
2.0 Credits / Lung Cancer, Oncology, Pulmonology/Respiratory
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer
1.5 Credit / Lung Cancer, Oncology, Pulmonology
View More
Most PCPs Unfamiliar With Biologic Therapy for Patients With Severe Asthma
December 24th 2023Two posters presented at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting evaluated real-world biologic utilization for patients with severe, uncontrolled asthma.
Read More
Severe Asthma Exacerbations: Spotlighting Trends Before and After COVID-19 Restrictions
December 7th 2023The study’s investigators suggest the results in this patient population may indicate rises in clinically diagnosed viral infections from viruses other than SARS-CoV-2 following pandemic lockdown changes.
Read More
Prediction Model Effective for Community-Acquired Pneumonia in Those With Acute Asthma Exacerbations
November 4th 2023This newly developed prediction model evaluating community-acquired pneumonia risk was noted to demonstrate accuracy, strong discriminatory qualities, and practicability in clinical settings.
Read More